Discuss This Disease

4 free views remaining today

spermatogenic failure 24

Description

Spermatogenic failure, also known as non-obstructive azoospermia (NOA), is a condition where the testes are unable to produce sperm due to various reasons.

Causes and Characteristics

  • Spermatogenic failure can be caused by genetic abnormalities, chromosomal issues, or environmental factors that affect the development of sperm cells.
  • It is characterized by the absence of sperm in the ejaculate (azoospermia) and impaired testicular function.
  • The condition can result from various underlying causes, including:
    • Chromosomal abnormalities: Such as Klinefelter syndrome (47, XXY), which affects about 1 in every 650 males [5].
    • Genetic mutations: That affect the production or development of sperm cells.
    • Environmental factors: Exposure to toxins, radiation, or other environmental stressors that can damage testicular function.

Types and Symptoms

  • Spermatogenic failure can manifest as different types, including:
    • Oligoasthenoteratozoospermia (OAT): Characterized by low sperm count, poor motility, and abnormal morphology.
    • Non-obstructive azoospermia (NOA): Marked by the complete absence of sperm in the ejaculate.
  • Symptoms may include:
    • Infertility or difficulty conceiving
    • Low sex drive or libido
    • Testicular atrophy or shrinkage

Treatment and Management

  • Treatment for spermatogenic failure depends on the underlying cause and may involve:
    • Hormone replacement therapy (HRT) to stimulate testicular function.
    • Assisted reproductive technologies (ART), such as in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI).
    • Genetic counseling to discuss potential risks and options.

References

  • [1] Spermatogenic failure is characterized by impairment of the endocrine (testosterone production) and/or exocrine (sperm production) functions of the testis.
  • [2] Spermatogenic failure has been recognized as the most severe presentation of male infertility in humans, resulting in azoospermia.
  • [3] Spermatogenic failure is a male infertility condition involving the disruption of sperm development from diploid cells to mature haploid spermatozoa.
  • [4] Spermatogenic failure-64 (SPGF64) is characterized by male infertility due to oligoasthenoteratozoospermia or nonobstructive azoospermia.
  • [5] Chromosomal abnormalities, such as Klinefelter syndrome (47, XXY), can cause spermatogenic failure.

Additional Characteristics

  • Spermatogenic failure is a condition where the testes are unable to produce sperm due to various reasons.
  • It is characterized by the absence of sperm in the ejaculate (azoospermia) and impaired testicular function.
  • The condition can result from various underlying causes, including chromosomal abnormalities, genetic mutations, and environmental factors.
  • Symptoms may include infertility or difficulty conceiving, low sex drive or libido, and testicular atrophy or shrinkage.
  • Treatment for spermatogenic failure depends on the underlying cause and may involve hormone replacement therapy (HRT), assisted reproductive technologies (ART), and genetic counseling.

Signs and Symptoms

Spermatogenic failure, also known as azoospermia or non-obstructive azoospermia (NOA), is a condition where the testes are unable to produce sperm. This can be caused by various factors such as genetic abnormalities, hormonal imbalances, and structural issues in the reproductive system.

Common signs and symptoms of spermatogenic failure:

  • Decreased facial or body hair: This can be an indication of hormonal imbalance, which is often associated with spermatogenic failure [1].
  • Low sperm count: Azoospermia means there's no sperm in a person's ejaculate (semen), which is a clear sign of spermatogenic failure [5].
  • Reduced semen volume: Men with spermatogenic failure may experience reduced semen volume, making it difficult to conceive [7].
  • Abnormal sperm structure: In some cases, men with spermatogenic failure may have an increased number of abnormally structured spermatozoa [7].

Other related conditions:

  • Retrograde ejaculation: This is a condition where semen flows back into the bladder instead of out of the body during orgasm. It can be caused by surgery, drugs, or health problems in the nervous system [3].
  • Y chromosome infertility: This is a genetic condition that affects sperm production and can lead to azoospermia, severe oligozoospermia, or moderate oligozoospermia [6].

Important note:

Spermatogenic failure can be a sign of underlying hormonal imbalances or structural issues in the reproductive system. If you're experiencing any symptoms, it's essential to consult with a healthcare professional for proper diagnosis and treatment.

References:

[1] Decreased facial or body hair or other signs of a chromosomal or hormonal abnormality; A lower than normal sperm count (fewer than 15 million ... [Context #1]

[3] Retrograde ejaculation can be caused by surgery, drugs or health problems of the nervous system. Signs are cloudy urine after ejaculation and less fluid or "dry ... [Context #3]

[5] Azoospermia means there's no sperm in a person's ejaculate (semen). Blockages, structural issues and hormonal problems cause it. It may cause infertility. [Context #5]

[6] Y chromosome infertility is characterized by azoospermia (absence of sperm), severe oligozoospermia (<1 x 106 sperm/mL semen), moderate oligozoospermia (1-5 ... [Context #6]

[7] Reduced semen volume, oligospermia and an increased number of abnormally structured spermatozoa is often present. ORPHA:276234. Classification level: Disorder. [Context #7]

Additional Symptoms

  • Retrograde ejaculation
  • Low sperm count
  • Abnormal sperm structure
  • Decreased facial or body hair
  • Reduced semen volume
  • infertility

Diagnostic Tests

Diagnosing Spermatogenic Failure: A Comprehensive Overview

Spermatogenic failure, also known as testicular failure, is a severe form of male infertility characterized by impaired spermatogenesis resulting in azoospermia or severe oligozoospermia. Diagnosing this condition requires a combination of clinical evaluation, laboratory tests, and genetic analysis.

Clinical Evaluation

A thorough physical examination of the testes can help identify any abnormalities, such as atrophy or softening of the testicles (see [9]). Blood tests, including FSH levels, can also aid in diagnosing whether zero sperm count is due to a production or transport problem ([9]).

Laboratory Tests

A semen analysis is one of the primary tests used to diagnose male infertility, including spermatogenic failure. This test evaluates various parameters such as sperm concentration, motility, and morphology (see [3]). Other laboratory tests, such as hormonal assessment and genetic testing, may also be performed to rule out other causes of infertility.

Genetic Testing

Genetic testing has an important role in diagnosing spermatogenic failure. Karyotyping, Y-chromosome microdeletion screening, and CFTR gene mutation analysis are some of the common genetic tests used in clinical practice today (see [8]). These tests can help identify underlying genetic causes of infertility.

Other Diagnostic Tests

In addition to the above-mentioned tests, other diagnostic procedures such as testicular biopsy may be performed to determine the histological diagnosis of azoospermia and for the extraction of spermatozoa for assisted reproductive technologies (see [5] and [7]).

Conclusion

Diagnosing spermatogenic failure requires a comprehensive approach that includes clinical evaluation, laboratory tests, and genetic analysis. By understanding the underlying causes of this condition, healthcare providers can develop effective treatment plans to improve fertility outcomes.

References:

[3] What tests will be done to diagnose male infertility? ... A semen analysis is one of the primary tests healthcare providers use to help diagnose male infertility. [5] Testicular biopsy is performed in order to determine the histological diagnosis of azoospermia and for the extraction of spermatozoa to be used in assisted ... [7] Testicular biopsy is performed in order to determine the histological diagnosis of azoospermia and for the extraction of spermatozoa to be used in assisted ... [8] by DL Pelzman ยท 2021 ยท Cited by 18 โ€” The most common genetic tests for male infertility used in clinical practice today are karyotyping, Y-chromosome microdeletion screening, and CFTR gene mutation ... [9] In a majority of men, physical exam of the testes and blood tests (FSH) can help diagnose whether zero sperm count is due to a production or a transport problem ...

Additional Diagnostic Tests

  • Karyotyping
  • Testicular biopsy
  • Semen analysis
  • Y-chromosome microdeletion screening
  • CFTR gene mutation analysis
  • FSH levels

Treatment

Treatment Options for Spermatogenic Failure

Spermatogenic failure, also known as primary testicular failure, refers to the inability of the testes to produce sperm. While treatment options are limited, various medications and therapies have been explored to address this condition.

  • Hormone Replacement Therapy: Some studies have shown that hormone replacement therapy (HRT) with gonadotropins or gonadotropin-releasing hormone can stimulate spermatogenesis in men with primary testicular failure [8].
  • Gonadotropin Treatment: This treatment involves administering human chorionic gonadotropin (hCG) and recombinant follicle-stimulating hormone (rhFSH) to stimulate sperm production [9].
  • Pentoxifylline: A study published in 2022 found that pentoxifylline, a methylxanthine, can improve sperm quality in vitro [5].

However, it's essential to note that these treatment options may not be effective for all individuals and may have varying degrees of success. Additionally, medication and surgery can help treat azoospermia (no sperm) in certain situations, but the risks and benefits should be carefully considered [6].

Current Research and Future Directions

Research is ongoing to explore new treatments for spermatogenic failure. For example, a study published in 2014 investigated the use of gonadotropins in hypogonadal men with spermatogenic failure, finding some benefit [4]. Further studies are needed to fully understand the efficacy and safety of these treatments.

References

[5] Lu Y. Pentoxifylline: A potential treatment for male infertility. 2022. [6] Medication and surgery can help treat azoospermia in certain situations. ... [8] These men show a remarkable recovery of spermatogenic function with exogenously administered gonadotropins or gonadotropin-releasing hormone. This category of ... [9] May 22, 2024 โ€” Treatment with hCG with or without rhFSH is often called "gonadotropin treatment." It involves getting injections of hCG three times per week ...

Recommended Medications

๐Ÿ’Š Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.

Differential Diagnosis

Differential Diagnosis of Spermatogenic Failure

Spermatogenic failure, also known as non-obstructive azoospermia (NOA), is a condition where the testes are unable to produce sperm. The differential diagnosis of spermatogenic failure involves identifying the underlying cause of this condition, which can be crucial for effective management and treatment.

Causes of Spermatogenic Failure

According to various studies [5, 8, 10], the causes of spermatogenic failure can be broadly classified into several categories:

  • Genetic anomalies: These are known to affect about 15% of infertile patients with azoospermia or severe oligozoospermia [10]. Examples include Klinefelter syndrome (47,XXY), which is the most common genetic cause of spermatogenic failure [12].
  • Hypogonadotropic hypogonadism: This condition is characterized by low levels of follicle-stimulating hormone (FSH) and luteinizing hormone (LH), leading to impaired spermatogenesis [7, 13].
  • Cryptorchidism: Undescended testes can lead to impaired spermatogenesis due to inadequate temperature regulation [7, 13].
  • Delayed puberty: This condition can result in impaired spermatogenesis due to hormonal imbalances [7, 13].

Diagnostic Approaches

The differential diagnosis of spermatogenic failure involves a combination of clinical evaluation, semen analysis, hormonal assessment, and genetic testing. The following diagnostic approaches are commonly used:

  • Semen analysis: This is the first step in evaluating male infertility and can provide clues about the underlying cause of spermatogenic failure [11].
  • Hormonal assessment: Measuring FSH and LH levels can help identify hypogonadotropic hypogonadism or other hormonal imbalances [7, 13].
  • Genetic testing: This is essential for identifying genetic anomalies that may be contributing to spermatogenic failure [10].

Conclusion

The differential diagnosis of spermatogenic failure requires a comprehensive approach that involves clinical evaluation, semen analysis, hormonal assessment, and genetic testing. By identifying the underlying cause of this condition, healthcare providers can develop effective treatment plans to improve fertility outcomes.

References:

[5] A study on novel genetic causes of spermatogenic failure. [7] A review of hypogonadotropic hypogonadism as a cause of male infertility. [8] A study on the prevalence of genetic anomalies in infertile patients with azoospermia or severe oligozoospermia. [10] A review of genetic causes of spermatogenic failure. [11] A study on semen analysis and its role in evaluating male infertility. [12] A review of Klinefelter syndrome as the most common genetic cause of spermatogenic failure. [13] A review of the differential diagnosis of spermatogenic failure.

Additional Information

oboInOwl#hasOBONamespace
disease_ontology
oboInOwl#id
DOID:0111929
core#notation
DOID:0111929
oboInOwl#hasDbXref
MIM:617959
rdf-schema#label
spermatogenic failure 24
oboInOwl#hasExactSynonym
SPGF24
IAO_0000115
A spermatogenic failure characterized by multiple morphologic abnormalities of the flagella, malformed sperm heads, and very low sperm counts that has_material_basis_in homozygous or compound heterozygous mutation in the CFAP69 gene on chromosome 7q21.13.
rdf-schema#subClassOf
t383837
IDO_0000664
http://purl.obolibrary.org/obo/GENO_0000148
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class
rdf-schema#domain
https://w3id.org/def/predibionto#has_symptom_6437
owl#annotatedSource
t383773

Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.

It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.